These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19509066)

  • 1. Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland.
    Prost G; Bernier-Valentin F; Croset M; Rousset B
    Endocr Relat Cancer; 2009 Sep; 16(3):873-84. PubMed ID: 19509066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connexin-32 acts as a downregulator of growth of thyroid gland.
    Prost G; Bernier-Valentin F; Munari-Silem Y; Selmi-Ruby S; Rousset B
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E291-9. PubMed ID: 18042666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
    Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
    Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.
    Jin L; Burniat A; Dumont JE; Miot F; Corvilain B; Franc B
    Br J Cancer; 2008 Dec; 99(11):1874-83. PubMed ID: 18985036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases.
    Căpraru OM; Berger N; Gadot N; Decaussin-Petrucci M; Zhang C; Borda A; Szilágyi T; Borson-Chazot F; Selmi-Ruby S
    Rom J Morphol Embryol; 2016; 57(1):91-8. PubMed ID: 27151693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
    Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
    Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.
    Shinohara S; Rothstein JL
    Oncogene; 2004 Sep; 23(45):7571-9. PubMed ID: 15326486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis.
    Hirabayashi Y; Yoon BI; Tsuboi I; Huo Y; Kodama Y; Kanno J; Ott T; Trosko JE; Inoue T
    Exp Biol Med (Maywood); 2007 May; 232(5):700-12. PubMed ID: 17463168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression.
    Pufnock JS; Rothstein JL
    J Immunol; 2009 May; 182(9):5498-506. PubMed ID: 19380798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
    Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
    Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.
    Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M
    Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.
    Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M
    Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cell proliferation in response to forced expression of gap junction proteins.
    Flachon V; Tonoli H; Selmi-Ruby S; Durand C; Rabilloud R; Rousset B; Munari-Silem Y
    Eur J Cell Biol; 2002 May; 81(5):243-52. PubMed ID: 12067060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
    Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM
    Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
    Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
    Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of three-dimensional thyroid follicle-like structures by polarized FRT cells made communication competent by transfection and stable expression of the connexin-32 gene.
    Tonoli H; Flachon V; Audebet C; Callé A; Jarry-Guichard T; Statuto M; Rousset B; Munari-Silem Y
    Endocrinology; 2000 Apr; 141(4):1403-13. PubMed ID: 10746644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory mediators and genetic background in oncogene mediated tumor progression.
    Russell JP; Engiles JB; Rothstein JL
    J Immunol; 2004 Apr; 172(7):4059-67. PubMed ID: 15034017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.